Tess Martin's research while affiliated with Hôpital Européen Georges-Pompidou (Hôpitaux Universitaires Paris-Ouest) and other places
What is this page?
This page lists the scientific contributions of an author, who either does not have a ResearchGate profile, or has not yet added these contributions to their profile.
It was automatically created by ResearchGate to create a record of this author's body of work. We create such pages to advance our goal of creating and maintaining the most comprehensive scientific repository possible. In doing so, we process publicly available (personal) data relating to the author as a member of the scientific community.
If you're a ResearchGate member, you can follow this page to keep up with this author's work.
If you are this author, and you don't want us to display this page anymore, please let us know.
It was automatically created by ResearchGate to create a record of this author's body of work. We create such pages to advance our goal of creating and maintaining the most comprehensive scientific repository possible. In doing so, we process publicly available (personal) data relating to the author as a member of the scientific community.
If you're a ResearchGate member, you can follow this page to keep up with this author's work.
If you are this author, and you don't want us to display this page anymore, please let us know.
Publications (5)
The purpose of this article is to investigate the common facilitators and barriers associated with the implementation of hospital-based health technology assessment (HB-HTA) across diverse hospital settings in seven countries. Through a two-round Delphi study, insights were gathered from a panel of 15 HTA specialists from France, Hungary, Italy, Ka...
An ambitious reform of the early access (EA) process was set up in July 2021 in France, aiming to simplify procedures and accelerate access to innovative drugs.
This study analyzes the characteristics of oncology drug approvals through the EA process and its impact on real-life data for oncology patients.
The number and characteristics of EA demand...
Objectives
To better understand the process of hospital acquisition of innovative medical devices (MDs) and the hospital-based health technology assessment (HB-HTA) pathways in France, an in-depth study based on a quantitative approach is needed. The aim of the present study was to assess through a national survey how HB-HTA is currently implemente...
Introduction:
Artificial Intelligence-based Medical Devices (AI-based MDs) are experiencing exponential growth in healthcare. This study aimed to investigate whether current studies assessing AI contain the information required for health technology assessment (HTA) by HTA bodies.
Methods:
We conducted a systematic literature review based on the...
Citations
... In 2023, a study was conducted in France among hospitals, focusing specifically on the adoption of innovative medical devices [30]. France showcases a diverse landscape of HB-HTA organizations across various structural levels, particularly within the different categories of hospitals. ...
![[object Object]](https://i1.rgstatic.net/ii/profile.image/278586591334400-1443431627297_Q64/Nicolas-Martelli.jpg)
... These devices use advanced algorithms and machine learning techniques to analyze complex medical data sets, thereby providing valuable insights and support to health care professionals in their decision-making. To meet the ever-increasing demand for integration of AI-based medical devices into clinical practice, their efficient evaluation through adapted health technology assessment (HTA) is now crucial [4]. Several frameworks have been published showing an adaptation of items for reporting clinical trials related to AI-based medical devices (Table 1). ...
![[object Object]](https://i1.rgstatic.net/ii/profile.image/522587353686016-1501605942733_Q64/Line-Farah-3.jpg)
